Effect of Combination of Anticytokine Preparations Anaferon and Artrofoon on Immune Inflammation in Rheumatoid Arthritis

  title={Effect of Combination of Anticytokine Preparations Anaferon and Artrofoon on Immune Inflammation in Rheumatoid Arthritis},
  author={V. I. Petrov and A. R. Babaeva and K. S. Solodenkova and E. V. Cherevkova and Yu. A. Zabolotneva and M. V. Kachanova and Svetlana Alexandrovna Sergeeva},
  journal={Bulletin of Experimental Biology and Medicine},
Treatment with a combination of artrofoon and anaferon significantly reduced clinical and laboratory parameters of rheumatoid inflammation and significantly decreased the content of antiinflammatory cytokines in the blood. These findings attest to antiinflammatory and immunomodulating effects of these preparations. 
Demographic Characteristics of Participants in Rheumatoid Arthritis Randomized Clinical Trials
This systematic review examines the representation in rheumatoid arthritis randomized clinical trials of racial/ethnic minority groups compared with the representation of these populations in the
[The phenomenon of release activity and the hypothesis of "spatial" homeostasis].
  • O. Epstein
  • Biology
    Uspekhi fiziologicheskikh nauk
  • 2013
It was shown that dilutions of parent substance prepared using this technology have one common peculiarity - they are capable to exert direct modifying effect on parent substance altering spatial structure ofparent substance and consequently its physical, chemical and biological properties.


Kaposi’s sarcoma associated with tumour necrosis factor α neutralising therapy
The case of Kaposi’s sarcoma is reported, and an association between TNFα inhibition and tuberculosis has been shown, and several cases of serious infections and malignant complications have been described.
Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritis
The first DMARD course in a patient seems to be safer than the consecutive ones, and the incidence of adverse events appears to be similar for high and low dose treatment.
Infliximab in active early rheumatoid arthritis
Early intervention with infliximab in patients with active RA despite MTX therapy may provide long term benefits by preventing radiographic progression and preserving joint integrity.
Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy.
A high level of suspicion of infection is necessary in patients under anti-TNF-alpha therapy and additional strategies for the prevention, rapid identification and pre-emptive therapy of such infections are suggested.
Severe septicaemia in a patient with polychondritis and Sweet’s syndrome after initiation of treatment with infliximab
Evidence suggests that an immunological reaction of unknown specificity is the underlying mechanism of Sweet’s syndrome, and a 51 year old white man with relapsing polychondritis with a five week history of general malaise, fever, recurrent arthritis, and complaints of morning stiffness is admitted.
Pharmacology of Ultralow Doses of Antibodies to Endogenous Regulators of Functions [in Russian
  • 2005
  • Rheum. Dis.,
  • 2003